Evidence-backed FAQ
Can you take ashwagandha every day?
NIH guidance describes short-term tolerability observations for ashwagandha over about three months, while safety over longer periods remains unknown.[1]
Important limitations
Short studies cannot establish safety for every person, preparation, or duration of use.[1]
What the evidence shows
Short studies cannot establish safety for every person, preparation, or duration of use.[1]
What the cited evidence shows
NIH guidance describes short-term tolerability observations for ashwagandha over about three months, while safety over longer periods remains unknown. Short studies cannot establish safety for every person, preparation, or duration of use.[1]
What timing and cycling protocols cannot tell us
The selected Shoden stress trial and Sensoril postmenopause trial used daily scheduled supplementation, with an after-dinner dose or morning/evening doses after meals; neither randomized participants to alternative dosing times, cycling, tapering or stopping schedules. These protocols do not identify the best time of day, prove food improves absorption, establish a cycling schedule, or determine how effects persist after discontinuation. Their 60-day and 24-week observation periods are not evidence of safety or efficacy over years.[2], [3]
Safety belongs in the decision
NIH guidance describes short-term tolerability observations for ashwagandha over about three months, while safety over longer periods remains unknown. Short studies cannot establish safety for every person, preparation, or duration of use.[1]
Read the supporting evidence summaries
The linked research pages provide study populations, formulations, doses, outcomes, and limitations in greater detail.
Related questions
References
- Ashwagandha: Usefulness and Safety. NIH National Center for Complementary and Integrative Health. Retrieved 2026-09-30. Government health fact sheet View source →
- An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.. Medicine. 2019. Randomized controlled trial View source →
- Ashwagandha and Shatavari Extracts Dose-Dependently Reduce Menopause Symptoms, Vascular Dysfunction, and Bone Resorption in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study.. Journal of menopausal medicine. 2025. Primary study View source →